BNIP3 and neoplasm: YFSJ and its component quercetin can inhibit the overactivation of skeletal muscle mitophagy mediated by the abnormal activation of the Stat3/HIF-1α/BNIP3 signaling pathway induced by the tumor inflammatory microenvironment, thereby alleviating CRF.